Company research

BillionToOne, Inc. Class A Common Stock (BLLN) stock fundamentals

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the sing

As of 2026-10-09

Exchange
XNAS
Sector
Healthcare
Industry
Diagnostics & Research

Read this company snapshot

Step 1 of 3

Daily valuation snapshot

BillionToOne, Inc. Class A Common Stock: source evidence dated 2026-10-09.

Daily close (USD)
$98.09
Market capitalization (USD)
$4,628,576,557.42
Price / earnings (TTM)
122.73
Price / book
8.62
What you should see

The source values and product destination above identify the example to inspect.

Step 2 of 3

What business is this, and what does its dated valuation mean?

Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.

Daily valuation dataset and column definitions
What you should see

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Step 3 of 3

Research BLLN in the app

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Research BLLN in the app
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Company overview

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a test that provides longitudinal determination of cancer burden through methylation assessment. The company was incorporated in 2016 and is headquartered in Menlo Park, California.

Daily valuation snapshot

See the complete daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing BLLN with another company.

Scroll sideways to compare all columns. Select a heading to sort.

Daily close (USD)$98.09
Market capitalization (USD)$4,628,576,557.42
Price / earnings (TTM)122.73
Price / book8.62

Read BLLN's valuation metrics

  1. Company size

    BillionToOne, Inc. Class A Common Stock's recorded market capitalization is $4,628,576,557.42. It measures the market value of the company's equity, rather than its revenue or cash balance.

  2. Price relative to earnings

    BLLN's recorded P/E is 122.73: about $122.73 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.

  3. Price relative to book equity

    BLLN's recorded price-to-book ratio is 8.62. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.

Research BillionToOne, Inc. Class A Common Stock with Aurora

Use the snapshot above to ask a specific question about BLLN. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow BLLN's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.